[1] [No authors listed]. Martindale:The Complete Drug Reference Brayfield Alison(Ed) Martindale:The Complete Drug Reference £459 4,688pp Pharmaceutical Press 9780857111395 0857111396 [Formula:see text][J]. Emerg Nurse, 2014,22(5):12.[2] Pommier Y, Leo E, Zhang H, et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs[J]. Chem Biol, 2010,17(5):421-433.[3] Pang B, Qiao X, Janssen L, et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin[J]. Nat Commun, 2013,4:1908-1908.[4] Lao J, Madani J, Puértolas T, et al. Liposomal Doxorubicin in the treatment of breast cancer patients:a review[J]. J Drug Deliv, 2013,2013:456409.[5] Wang Y, Kang G, Liu J, et al. Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(Ⅱ) with high anti-tumor activity and low side reaction[J]. Metallomics, 2012,4(5):441-447.[6] Li S, Wang Y, Zhao M, et al. BPIC:A novel anti-tumor lead capable of inhibiting inflammation and scavenging free radicals[J]. Bioorg Med Chem Lett, 2015,25(5):1146-1150. |